Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 141 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1401 8.5 months Hepatocellular carcinoma 4 Radiation
National Institute of Cancer Research Taiwan Region 1/2011
Treatment Details: Patients: In this study, patients with hepatocellular carcinoma were divided into 2 treatment groups. Group A included 18 patients, 83.3% were male and 72.2% were under the age of 70. In
 
1402 8.5 months Malignant pleural mesothelioma 4 Chemotherapy
Finsen Centre/National University Hospital Denmark 2/2007
Treatment Details: Patients: This study involved patients with malignant pleural mesothelioma who had previously been treated with platinum-based chemotherapy. Patients were divided into two separate treatme
 
1403 8.5 months Recurrent GBM 5 Biologic therapy
Chemotherapy
Duke University Medical Center United States 7/2011
Treatment Details: Patients: This study involved 32 patients with recurrent glioblastoma who had been previously treated with radiation therapy and temozolomide. The median patient age was 56 years and 59% w
 
1404 8.4 months Advanced hepatocellular carcinoma 4 Biologic therapy
Massachusetts General Hospital Cancer Center United States 4/2011
Treatment Details: Patients: This study involved 28 patients with advanced hepatocellular carcinoma. The median patient age was 65 years (range of 33-81) and 64% were male. Treatment: Patients were treat
 
1405 8.4 months Recurrent GBM 2 Immunotherapy
Osaka University Graduate School of Medicine Japan 5/2008
Treatment Details: Patients: This phase II study involved 21 patients (7 women and 14 men) with recurrent glioblastoma multiforme. They ranged in age from 20 to 76 years old. Treatment: Patients were
 
1406 8.4 months Recurrent or progressive GBM 5 Biologic therapy
Gene Therapy
Surgery
University of California, San Francisco United States 12/2003
Treatment Details: Patients: This Phase I/II multi-institutional trial involved 30 patients with progressive or recurrent glioblastoma multiforme. Treatment: Treatment consisted of surgical resection of tum
 
1407 8.4 months metastatic melanoma 4 Chemotherapy
Immunotherapy
University of Tubingen Germany 9/2005
Treatment Details: Patients: This Phase III study involved a total of 271 patients with metastatic melanoma who were divided into two groups: Group A of 137 patients and Group B of 134 patients. For Group A t
 
1408 8.4 months Advanced NSCLC 2 Chemotherapy
Christie Hospital NHS Trust United Kingdom 7/2005
Treatment Details: Patients: This Phase II study involved 17 patients with advanced non-small-cell lung cancer. Eleven patients were men, and six were women. The median age was 62 years, and none of the patie
 
1409 8.4 months Stage IV melanoma 4 Chemotherapy
Immunotherapy
Istituto Oncologico Veneto Italy 6/2011
Treatment Details: Patients: This phase III study involved stage IV melanoma patients who were divided into two separate treatment groups. Group A consisted of 75 patients with a median age of 54.5 years and
 
1410 8.3 months NSCLC 5 Chemotherapy
Yale Cancer Center and Smilow Cancer Hospital United States 4/2012
Treatment Details: Patients: This phase II study involved non-small cell lung cancer patients who had not been previously treated with chemotherapy and were divided into separate treatment groups. Group A co
 
Page 141 of 187  | Previous Page  | Next Page